Baron and Budd Sponsors Updated Mesothelioma Patient Guidelines from NCCN

December 13, 2012  |  Mesothelioma, Press Releases

Newly Updated Book Offers Latest Information on Treatments for Malignant Pleural Mesothelioma

DALLAS –(December 13, 2012) –Baron and Budd, a national law firm dedicated to protecting the rights of mesothelioma patients, has underwritten the printing and distribution of the updated patient guidelnes from the National Comprehensive Cancer Network® (NCCN®). Made possible by the generous support of the mesothelioma lawyers at Baron and Budd, these new guidelines are a translation of the latest version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). The guidelines are currently available for free download from and

The updated NCCN Guidelines for Patients®: Malignant Pleural Mesothelioma translates the latest version of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Malignant Pleural Mesothelioma into an understandable resource for patients and caregivers. The updated NCCN Guidelines for Patients®: Malignant Pleural Mesothelioma give patients access to information about the most recent advancements in mesothelioma treatment to help them make informed decisions about their care.

The NCCN Guidelines® are the centerpiece of the NCCN. The Guidelines are created by multidisciplinary panels of cancer experts from NCCN member cancer centers. The NCCN Guidelines for Patients® translate these clinical guidelines into patient-friendly materials that offers understandable information for patients seeking to make informed decisions about their cancer treatment.

“Since mesothelioma is only diagnosed in approximately 3,000 people each year, it can be difficult for patients to find quality resources about treatment,” said Russell Budd, founder and managing shareholder of Baron and Budd and Board member of the NCCN Foundation Board. “As a firm dedicated to mesothelioma patients, we wanted to help bring valuable information to patients suffering from this horrible cancer. We are proud to partner with the NCCN on the translation of these updated guidelines.”

Baron and Budd was one of the first law firms to successfully handle a mesothelioma lawsuit in the United States and is proud to continue fighting on behalf of mesothelioma patients 35 years later. Under the leadership of firm founder Russell Budd, Baron and Budd has contributed to numerous non-profit organizations to help advocate for asbestos victims and find a cure for mesothelioma. Budd is the only attorney who holds a seat on the Board of the NCCN Foundation. The firm was also an inaugural donor to the International Mesothelioma Program (IMP) at Brigham and Women’s in Boston and a 2013 Platinum-level sponsor of the Asbestos Disease Awareness Organization (ADAO). Baron and Budd also previously underwrote the book Understanding Mesothelioma from CURE media group.

For a complimentary copy physical copy of the updated NCCN Guidelines for Patients®: Malignant Pleural Mesothelioma, call 1.866.855.1229 or fill out our online form.

About Baron & Budd, P.C.

The national mesothelioma law firm of Baron & Budd, P.C. has a more than 30-year history of “Protecting What’s Right” for asbestos sufferers and their families. As one of the first law firms to successfully litigate an asbestos lawsuit, Baron & Budd continues to actively represent veterans, industry workers and others who are suffering as a result of exposure to asbestos. Baron & Budd achieved the largest mesothelioma verdict ever in the state of Texas, a $55 million verdict for an asbestos sufferer and his family in El Paso, Texas. Contact Baron and Budd at 1.866.855.1229 for additional information on mesothelioma treatments, mesothelioma cancer doctors and treatment centers and mesothelioma attorneys.

News Articles

View All

  • Get Answers Now

    Get a free case evaluation to help determine your legal rights.

  • Receive emails from Baron & Budd?
  • Receive text messages from Baron & Budd?
  • This field is for validation purposes and should be left unchanged.